You are here

COVID Antibody Treatment Sotrovimab Approved for Use

Categories:

UK authorisation has been given for sotrovimab for patients with mild to moderate COVID-19 who are at risk of developing severe disease.

The Medicines and Healthcare products Regulatory Agency (MHRA) said that the single monoclonal antibody drug was a safe and effective treatment for reducing the risk of hospitalisation and death.

Results from a clinical trial, published as a preprint last month, suggested that a single dose of sotrovimab (Xevudy, GSK and Vir Biotechnology) reduced the risk of hospitalisation in high-risk adults for longer than 24 hours, or death within 29 days, by 79% (95% CI 50% to 91%) compared to placebo.

Sotrovimab works by binding to the spike protein on the outside of the COVID-19 virus to prevent it from attaching to and entering human cells.

https://www.medscape.co.uk/viewarticle/covid-antibody-treatment-sotrovimab-

Hi

Can I ask.please would we be able to take this if needed?

Apparently not yet...according to MHRA "in due course"

'Dr June Raine, MHRA chief executive said that sotrovimab was "yet another therapeutic that has been shown to be effective at protecting those most vulnerable to COVID-19, and signals another significant step forward in our fight against this devastating disease".

She said there had been "no compromises on quality, safety, and effectiveness".

The Government and the NHS will confirm how this COVID-19 treatment will be deployed to patients in due course, the MHRA said.

https://www.medscape.co.uk/viewarticle/covid-antibody-treatment-sotrovimab-approved-use-2021a1002her?uac=310212SY&impID=3842544&sso=true&faf=1&src=mkm_ret_211202_mscpmrk_newsalertuk_int

Meanwhile- take a look at this article "How Vitamin D Works to Fight COVID-19"

'A number of studies, such as those included in our new eBook, have provided much evidence showing the significant effect that vitamin D status has on COVID-19 disease progression and outcomes, where higher vitamin D levels can reduce the risk of infection and severity and help prevent death.'